David J. Richard

976 total citations
24 papers, 838 citations indexed

About

David J. Richard is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, David J. Richard has authored 24 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Organic Chemistry and 5 papers in Cancer Research. Recurrent topics in David J. Richard's work include PI3K/AKT/mTOR signaling in cancer (11 papers), Synthesis and biological activity (4 papers) and Synthesis and Biological Activity (3 papers). David J. Richard is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (11 papers), Synthesis and biological activity (4 papers) and Synthesis and Biological Activity (3 papers). David J. Richard collaborates with scholars based in United States, Canada and France. David J. Richard's co-authors include Madeleine M. Joullié, Jeroen C. Verheijen, Arie Zask, Ker Yu, Kevin J. Curran, Joshua A. Kaplan, Irwin Hollander, Lourdes Toral‐Barza, Judy Lucas and Semiramis Ayral‐Kaloustian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Communications.

In The Last Decade

David J. Richard

24 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Richard United States	18	500	419	61	55	47	24	838
Anne Mengel Germany	12	414 0.8×	623 1.5×	58 1.0×	64 1.2×	40 0.9×	18	967
Lawrence R. McGee United States	19	613 1.2×	742 1.8×	124 2.0×	58 1.1×	101 2.1×	28	1.3k
Paul A. Renhowe United States	18	412 0.8×	617 1.5×	56 0.9×	13 0.2×	29 0.6×	26	891
Hiroyuki Kakinuma Japan	14	325 0.7×	288 0.7×	45 0.7×	25 0.5×	20 0.4×	43	744
Andrew Madin United Kingdom	18	435 0.9×	815 1.9×	78 1.3×	13 0.2×	33 0.7×	35	1.1k
Dimitar Jakimov Serbia	17	262 0.5×	299 0.7×	50 0.8×	38 0.7×	35 0.7×	69	711
Yongqiang Zhu China	19	586 1.2×	207 0.5×	54 0.9×	33 0.6×	58 1.2×	71	983
Gregory R. Ott United States	20	462 0.9×	492 1.2×	95 1.6×	19 0.3×	51 1.1×	34	948
Samit K. Bhattacharya United States	17	269 0.5×	353 0.8×	93 1.5×	43 0.8×	42 0.9×	29	803
Brian A. Salvatore United States	20	487 1.0×	438 1.0×	80 1.3×	15 0.3×	108 2.3×	32	1.0k

Countries citing papers authored by David J. Richard

Since Specialization

Citations

This map shows the geographic impact of David J. Richard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Richard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Richard more than expected).

Fields of papers citing papers by David J. Richard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Richard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Richard. The network helps show where David J. Richard may publish in the future.

Co-authorship network of co-authors of David J. Richard

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Richard. A scholar is included among the top collaborators of David J. Richard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Richard. David J. Richard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ericsson, Anna, David J. Richard, Erik Wilker, et al.. (2024). FT-4202, a selective pyruvate kinase R activator for sickle cell disease. Experimental Hematology. 141. 104673–104673. 1 indexed citations

Lovering, Frank, Jeanne S. Chang, Christoph M. Dehnhardt, et al.. (2015). Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free‐Energy Perturbation (FEP). ChemMedChem. 11(2). 217–233. 35 indexed citations

Richard, David J., Thomas D. Bannister, William E. Pierceall, et al.. (2013). Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker. Bioorganic & Medicinal Chemistry. 21(21). 6642–6649. 43 indexed citations

Bannister, Thomas D., Marcel Koenig, Yuanjun He, et al.. (2013). ML311: A Small Molecule that Potently and Selectively Disrupts the Protein-Protein Interaction of Mcl-1 and Bim: A Probe for Studying Lymphoid Tumorigenesis. Europe PMC (PubMed Central). 6 indexed citations

Zask, Arie, Jeroen C. Verheijen, & David J. Richard. (2011). Recent advances in the discovery of small-molecule ATP competitive mTOR inhibitors: a patent review. Expert Opinion on Therapeutic Patents. 21(7). 1109–1127. 28 indexed citations

Verheijen, Jeroen C., David J. Richard, Kevin J. Curran, et al.. (2010). 2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: Optimization of human microsomal stability. Bioorganic & Medicinal Chemistry Letters. 20(8). 2648–2653. 22 indexed citations

Zask, Arie, Jeroen C. Verheijen, David J. Richard, et al.. (2010). Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(8). 2644–2647. 33 indexed citations

Curran, Kevin J., Jeroen C. Verheijen, Joshua A. Kaplan, et al.. (2010). Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): Optimization of the 1-substituent. Bioorganic & Medicinal Chemistry Letters. 20(4). 1440–1444. 61 indexed citations

Richard, David J., Jeroen C. Verheijen, Ker Yu, & Arie Zask. (2010). Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kα. Bioorganic & Medicinal Chemistry Letters. 20(8). 2654–2657. 22 indexed citations

10.

Moore, William, David J. Richard, & Atli Thorarensen. (2010). An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola. Expert Opinion on Therapeutic Patents. 20(12). 1703–1722. 17 indexed citations

11.

Richard, David J., Jeroen C. Verheijen, Kevin J. Curran, et al.. (2009). Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: Discovery of highly potent and selective analogs with improved human microsomal stability. Bioorganic & Medicinal Chemistry Letters. 19(24). 6830–6835. 42 indexed citations

12.

Zask, Arie, Joshua A. Kaplan, Kevin J. Curran, et al.. (2009). Abstract B145: Highly selective pyrazolopyrimidine mTOR inhibitors with profound in vivo antitumor activity. Molecular Cancer Therapeutics. 8(12_Supplement). B145–B145. 2 indexed citations

13.

Zask, Arie, Joshua A. Kaplan, Jeroen C. Verheijen, et al.. (2009). Morpholine Derivatives Greatly Enhance the Selectivity of Mammalian Target of Rapamycin (mTOR) Inhibitors. Journal of Medicinal Chemistry. 52(24). 7942–7945. 81 indexed citations

14.

Richard, David J., et al.. (2004). Synthetic studies of roquefortine C: Synthesis of isoroquefortine C and a heterocycle. Proceedings of the National Academy of Sciences. 101(33). 11971–11976. 38 indexed citations

15.

Joullié, Madeleine M. & David J. Richard. (2004). Cyclopeptide alkaloids: chemistry and biology. Chemical Communications. 2011–2015. 73 indexed citations

16.

Richard, David J., et al.. (2003). In vivo assays for phycotoxins. Helmholtz-Zentrum für Polar-und Meeresforschung (Alfred-Wegener-Institut). 31 indexed citations

17.

Richard, David J., et al.. (2001). Total Synthesis of Isoroquefortine C. The Journal of Organic Chemistry. 67(3). 620–624. 51 indexed citations

18.

Liang, Bo, David J. Richard, Padma Portonovo, & Madeleine M. Joullié. (2001). Total Syntheses and Biological Investigations of Tamandarins A and B and Tamandarin A Analogs. Journal of the American Chemical Society. 123(19). 4469–4474. 24 indexed citations

19.

Joullié, Madeleine M., Padma Portonovo, Bo Liang, & David J. Richard. (2000). Total synthesis of (−)-tamandarin B. Tetrahedron Letters. 41(49). 9373–9376. 26 indexed citations

20.

Schaffer, Stephen W., et al.. (1996). Direct determination of iron(II), iron(III) and total iron as UV-absorbing complexes by capillary electrophoresis. Journal of Chromatography A. 740(1). 151–157. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact